Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 16, Issue 11, Pages 1260-1270
Publisher
Springer Science and Business Media LLC
Online
2021-10-01
DOI
10.1038/s41565-021-00962-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolonged activation of innate immune pathways by a polyvalent STING agonist
- (2021) Suxin Li et al. Nature Biomedical Engineering
- Cytosolic Delivery of Thiolated Mn‐cGAMP Nanovaccine to Enhance the Antitumor Immune Responses
- (2021) Chengyun Chen et al. Small
- Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors
- (2021) Xue Yang et al. Nano Today
- Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy via Enhancing Innate Immunity
- (2020) Lin Hou et al. ACS Nano
- Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing
- (2020) Nicholas J. Bessman et al. SCIENCE
- NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists
- (2020) Christopher J. Nicolai et al. Science Immunology
- Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
- (2020) Yanpu He et al. Science Advances
- Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy
- (2020) Mengze Lv et al. CELL RESEARCH
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- T cell stemness and dysfunction in tumors are triggered by a common mechanism
- (2019) Suman Kumar Vodnala et al. SCIENCE
- Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.
- (2019) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- STING pathway agonism as a cancer therapeutic
- (2019) Blake A. Flood et al. IMMUNOLOGICAL REVIEWS
- ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
- (2019) Thomas Scambler et al. eLife
- Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
- (2019) Linda Schadt et al. Cell Reports
- HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING
- (2019) Xiaobo Luo et al. JOURNAL OF CLINICAL INVESTIGATION
- Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy
- (2018) Rui Kuai et al. BIOCONJUGATE CHEMISTRY
- One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy
- (2018) Yu Yang et al. BIOMATERIALS
- Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine
- (2018) Yee Sun Tan et al. CLINICAL CANCER RESEARCH
- Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses
- (2018) Chenguang Wang et al. IMMUNITY
- DNA-induced liquid phase condensation of cGAS activates innate immune signaling
- (2018) Mingjian Du et al. SCIENCE
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- LBA15Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
- (2018) K J Harrington et al. ANNALS OF ONCOLOGY
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- De-novo and acquired resistance to immune checkpoint targeting
- (2017) Nicholas L Syn et al. LANCET ONCOLOGY
- Channelling potassium to fight cancer
- (2016) K. George Chandy et al. NATURE
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
- (2015) S. Liu et al. SCIENCE
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
- (2014) Lingyin Li et al. Nature Chemical Biology
- Divalent cation signaling in immune cells
- (2014) Benjamin Chaigne-Delalande et al. TRENDS IN IMMUNOLOGY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D
- (2013) B. Chaigne-Delalande et al. SCIENCE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids
- (2012) Xiaoshan Shi et al. NATURE
- Nutritional immunity: transition metals at the pathogen–host interface
- (2012) M. Indriati Hood et al. NATURE REVIEWS MICROBIOLOGY
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors
- (2012) Manuela Rossol et al. Nature Communications
- MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP
- (2011) L. Jin et al. JOURNAL OF IMMUNOLOGY
- Manganese-based MRI contrast agents: past, present, and future
- (2011) Dipanjan Pan et al. TETRAHEDRON
- NF- B RelA Subunit Is Crucial for Early IFN- Expression and Resistance to RNA Virus Replication
- (2010) J. Wang et al. JOURNAL OF IMMUNOLOGY
- How the Noninflammasome NLRs Function in the Innate Immune System
- (2010) J. P. Y. Ting et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started